That is necessary, since the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be effective. In other words, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (legacy report prediction). Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. This was a development practically nobody saw. But it's going to have extensive ramifications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown genome sequencing). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it drew back maybe substantially before going higher - legacy report prediction. I've been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. But that's not the huge concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. first lady. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are so numerous fantastic private companies on the verge of hitting the public markets And I've been dealing with a brand-new way for you to invest even prior to these companies go public.
This chance has actually been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to schedule your area for totally free.
Emma Walsh here, managing editor of the Journal. Regular Journal readers understand that tech isn't our usual beat (jeff brown genome sequencing stock). And when it pertains to tech investing, we leave it to the specialists. Thankfully, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (jeff brown genome sequencing stock). In reality, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big picture and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing exponential development and developing incredible opportunities for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. genetic sequencing companies jeff brown. But despite what lots of readers might think, this is a pattern that's just beginning. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this ultimately resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (exponential tech investor). Losing two months of manufacturing and sales really impacts the number of 5G gadgets are sold in the fiscal year. When you consider all of that, offering 250 million systems is impressive. More significantly, the delays triggered by the pandemic created a load of bottled-up demand. Which demand is now going to be pressed into 2021. In reality, I anticipate that more than 500 million 5G devices will be shipped in 2021 - future report. Which's not my only 5G prediction When I have actually discussed 5G in the past, I have actually described its 3 different phases.
In Stage 2, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Phase 3, 5G services begin to be used (jeff brown biotech genome sequencing). That's when we start to see applications running on 5G networks. Consider things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summer. This starts something of a virtuous cycle: Most individuals don't really appreciate the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next essential innovation I visualize in 2021 is CRISPR genetic modifying. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it is among the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a similar concept however with our genetic code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For several years, CRISPR was mainly a niche technology that wasn't well comprehended. And during that time, there were really just three business operating in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing unbelievable returns. This entire industry is successfully a greenfield chance.
There's room for numerous business to exist in this area. jeff brown prediction for 2021. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that two or 3 more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things taking place at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software can precisely anticipate the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is necessary since the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental process. Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but a number of drug treatments produced using this technology. This was one of those advancements that nearly nobody discovered. But it's going to have profound ramifications for treating illness. And, obviously, there will be a lot of financial investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly significantly prior to going greater. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin - democratic republic. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. But at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. brownstone research. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information is up to date since February 2021, however we could not individually validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to select winning innovation stocks. He invested more than 25 years looking into innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent point of view on the market. He's always on the hunt for new chances, and he shares a lot of his best picks in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively predicted some of the biggest financial occasions of the past twenty years. Although he doesn't appear to release his choices to the public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal whenever, but Jeff Brown's accurate forecasts have earned him legions of dedicated followers. That says a lot about his ability. The Near Future Report is published by Brownstone Research, a popular financial research study publisher. Brownstone Research study provides numerous research study services with a variety of specializations - jeff brown investment prediction.
The business is likewise affiliated with Bonner & Partners, another well-respected research study publisher - united arab emirates. On its site, Brownstone states its objective is to provide retail financiers with professional-grade research: "For too long, the very best financial investment research has not been offered to individual investors. It has actually been typically scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown biotech pick. The mission of Brownstone Research study is to make that sort of exclusive research available to any investors wanting to gain an edge in the markets. The goal is easy to provide unique and lucrative financial investment research found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also serves as the company's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After years of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout many of America. If you understand even a bit about the market, you understand that he has a track record as a King Midas of sorts. melania trump. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown believes S.A.V. last week. could be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 cutting-edge technologies: expert system and electric vehicles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the vehicle industry's Holy Grail. As you know, electric automobiles and self-driving car stocks have been substantial this year, but the Wall Street maker has actually been huge on hype without much tangible outcome. In spite of an extreme increase in competition over the previous couple of years, Brown still thinks Musk has the very best possibility of putting all of it together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Lorry, and it might be the future of transportation. Essentially, this technology would enable you to lease your automobile as an autonomous, self-driving taxi when you're not using it. You simply leave the cars and truck and press a button on an app that informs the automobile to "join the fleet." Next thing you know, you're relaxing on your sofa while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a significant portion of the revenues. It sounds crazy, but it could be closed than you believe.